Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


New AMA Policy Aimed at Combatting Misinformation through Public Education Campaign to Promote Safety and Efficacy of COVID-19 Vaccines


 

CHICAGO - With misinformation about the COVID-19 vaccine development process circulating widely, physicians at the Special Meeting of the American Medical Association (AMA) House of Delegates adopted policy today aimed at educating physicians on speaking with patients about COVID-19 vaccination, bearing in mind the historical context of "experimentation" with vaccines and other medications in communities of color, and providing physicians with culturally appropriate patient education materials.

Educating the public about the safety and efficacy of the COVID-19 vaccine programs, particularly among populations that have been disproportionately impacted by COVID-19, is an urgent priority. Under the new policy, the AMA will help physicians address patient concerns, dispel misinformation, and build confidence in COVID-19 vaccination. The policy also calls for the AMA to form a coalition of health care and public health organizations, inclusive of those respected in communities of color, committed to developing and implementing a joint public education program promoting the facts about, and encouraging the acceptance of, COVID-19 vaccination.

"Given the unprecedented situation with COVID-19 and with vaccine development moving at a rapid pace, many of our patients and the public have questions and concerns. It is essential that we speak together as a strong unified voice across health care and public health, inclusive of organizations respected in communities of color, to use scientific, fact-based evidence to help allay public concerns and build confidence in COVID-19 vaccine candidates that are determined to be safe and effective," said AMA President Susan R. Bailey, M.D. "We will continue to monitor the scientific data regarding safety and effectiveness during and after the vaccine development process to ensure the proper safeguards are in place to deliver a safe and effective vaccine."

Building on the AMA's efforts over the last several months advocating for a clear and transparent COVID-19 vaccine development process, the new policy calls for the AMA to continue to monitor the process to ensure that the evidence continues to support safe and effective use of vaccines among recommended populations. In October, the AMA launched a webinar series to ensure physicians are continuously informed about the federal review process for COVID-19 vaccine candidates. The first two webinars featured fact-based insights from the nation's highest-ranking subject matter experts working to protect public health from the Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), including an overview of the FDA's vaccine review process and an update from the CDC on COVID-19 vaccine development and distribution.

 
Share:

Related Articles:


Recent Articles

Hot spots identified for colorectal cancer mortality rates among young women

Read More

ONcology Rounds

Read More

Minority Report

All cancers are not created equally. Recent Vanderbilt research show stomach, lung and appendiceal cancers are on the rise and detected later among certain ethnic groups.

Read More

Rounding on Addiction

Read More

Women and Addiction

Prenatal addiction services needed to bridge the gap in addiction, obstetrics

Read More

State of Recovery

Efforts are underway by TDMHSAS leadership to reach more Tennesseans suffering with addiction through education and recovery initiatives.

Read More

AMA Backs Policy Proposals to Cover More of the Uninsured

CHICAGO -- The American Medical Association (AMA) House of Delegates adopted principles today supporting public policy approaches that have the potential to expand insurance coverage to millions of the uninsured, including those who have lost their coverage during the COVID-19 pandemic.

Read More

Statins to be Studied for Prevention of Dementia, Disability, and Heart Disease

Vanderbilt University Medical Center (VUMC) researchers are enrolling adults age 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol, also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease.

Read More

Addressing Opioid Usage in the Hospital Setting

Opioid misuse often traces its roots to medically valid pain management intervention. Increased awareness of addiction has led providers to look for effective alternatives. In the hospital setting, recent studies find Caldolor® might be one such option.

Read More

Nashville Health Care Council: 25 Years Old & Growing

This year marks the 25th anniversary of the Nashville Health Care Council, an organization that was founded by the local health care community with the purpose of establishing Nashville as the nation's health care capital.

Read More

Email Print
 
 

 

 


Tags:
None
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: